595 related articles for article (PubMed ID: 31197405)
21. Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases.
Lorenzl S; Albers DS; LeWitt PA; Chirichigno JW; Hilgenberg SL; Cudkowicz ME; Beal MF
J Neurol Sci; 2003 Mar; 207(1-2):71-6. PubMed ID: 12614934
[TBL] [Abstract][Full Text] [Related]
22. A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease.
Johnston P; Chojnowski AJ; Davidson RK; Riley GP; Donell ST; Clark IM
J Hand Surg Am; 2007 Mar; 32(3):343-51. PubMed ID: 17336841
[TBL] [Abstract][Full Text] [Related]
23. Autophagy, its mechanisms and regulation: Implications in neurodegenerative diseases.
Moloudizargari M; Asghari MH; Ghobadi E; Fallah M; Rasouli S; Abdollahi M
Ageing Res Rev; 2017 Nov; 40():64-74. PubMed ID: 28923312
[TBL] [Abstract][Full Text] [Related]
24. Oxidative stress and neurotoxicity.
Sayre LM; Perry G; Smith MA
Chem Res Toxicol; 2008 Jan; 21(1):172-88. PubMed ID: 18052107
[TBL] [Abstract][Full Text] [Related]
25. Neuronal autophagy and neurodegenerative diseases.
Son JH; Shim JH; Kim KH; Ha JY; Han JY
Exp Mol Med; 2012 Feb; 44(2):89-98. PubMed ID: 22257884
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial diseases of the brain.
Chaturvedi RK; Flint Beal M
Free Radic Biol Med; 2013 Oct; 63():1-29. PubMed ID: 23567191
[TBL] [Abstract][Full Text] [Related]
27. Mitophagy Regulates Neurodegenerative Diseases.
Cen X; Zhang M; Zhou M; Ye L; Xia H
Cells; 2021 Jul; 10(8):. PubMed ID: 34440645
[TBL] [Abstract][Full Text] [Related]
28. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
29. Endogenous and synthetic MMP inhibitors in CNS physiopathology.
Baranger K; Rivera S; Liechti FD; Grandgirard D; Bigas J; Seco J; Tarrago T; Leib SL; Khrestchatisky M
Prog Brain Res; 2014; 214():313-51. PubMed ID: 25410364
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
31. Histone Methylation Regulation in Neurodegenerative Disorders.
Basavarajappa BS; Subbanna S
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925016
[TBL] [Abstract][Full Text] [Related]
32. Synapses in neurodegenerative diseases.
Bae JR; Kim SH
BMB Rep; 2017 May; 50(5):237-246. PubMed ID: 28270301
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases.
Shiomi T; Lemaître V; D'Armiento J; Okada Y
Pathol Int; 2010 Jul; 60(7):477-96. PubMed ID: 20594269
[TBL] [Abstract][Full Text] [Related]
34. P-gp transporter and its role in neurodegenerative diseases.
Rapposelli S; Digiacomo M; Balsamo A
Curr Top Med Chem; 2009; 9(2):209-17. PubMed ID: 19200006
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease.
Hroudová J; Singh N; Fišar Z
Biomed Res Int; 2014; 2014():175062. PubMed ID: 24900954
[TBL] [Abstract][Full Text] [Related]
36. Rat tail static compression model mimics extracellular matrix metabolic imbalances of matrix metalloproteinases, aggrecanases, and tissue inhibitors of metalloproteinases in intervertebral disc degeneration.
Yurube T; Takada T; Suzuki T; Kakutani K; Maeno K; Doita M; Kurosaka M; Nishida K
Arthritis Res Ther; 2012 Mar; 14(2):R51. PubMed ID: 22394620
[TBL] [Abstract][Full Text] [Related]
37. Tissue inhibitors of metalloproteinases.
Murphy G
Genome Biol; 2011 Nov; 12(11):233. PubMed ID: 22078297
[TBL] [Abstract][Full Text] [Related]
38. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.
Candelario-Jalil E; Yang Y; Rosenberg GA
Neuroscience; 2009 Feb; 158(3):983-94. PubMed ID: 18621108
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of cell death in neurodegenerative diseases: fashion, fiction, and facts.
Graeber MB; Moran LB
Brain Pathol; 2002 Jul; 12(3):385-90. PubMed ID: 12146806
[TBL] [Abstract][Full Text] [Related]
40. Differential gene expression profiling of metalloproteinases and their inhibitors: a comparison between bovine intervertebral disc nucleus pulposus cells and articular chondrocytes.
Cui Y; Yu J; Urban JP; Young DA
Spine (Phila Pa 1976); 2010 May; 35(11):1101-8. PubMed ID: 20473119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
